SB39 Alabama 2019 Session
Bill Summary
Under existing law, the dispensing of a different drug or brand of a drug in lieu of the drug ordered or prescribed is prohibited except a pharmacist is authorized to dispense a less expensive pharmaceutically and therapeutically equivalent generic drug product prescribed by a licensed physician or other practitioner, including a practitioner located in another state. A written prescription issued in this state is required to have two signature lines, one designated "dispense as written" and one designated "product selection permitted." An oral prescription from a practitioner is required to specify whether a generic drug product may be dispensed. A violation is subject to a fine
This bill would delete the provision prohibiting dispensing a different drug or brand of drug and would specify that unless the physician or other practitioner indicates otherwise, a pharmacist may dispense either a brand name drug or a less expensive pharmaceutically or therapeutically equivalent generic drug product
The bill would also delete the requirement for a written prescription to contain two signature lines and the specified requirement for an oral prescription
Relating to pharmacists and the requirements for prescriptions and the dispensing of prescriptions; to amend Section 34-23-8 of the Code of Alabama 1975, to specify that, unless a physician or other practitioner indicates otherwise, a pharmacist may dispense a less expensive pharmaceutically or therapeutically equivalent drug product and to delete the specified requirements for a written or an oral prescription.
Bill Actions
Action Date | Chamber | Action |
---|---|---|
March 5, 2019 | S | Read for the first time and referred to the Senate committee on Healthcare |
Bill Text
Bill Documents
Type | Link |
---|---|
Bill Text | SB39 Alabama 2019 Session - Introduced |